Store
In Vitro Diagnostics Business Outlook, 2026
Publication Date: February 23, 2026
Tags: Coagulation, COVID-19, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: Varies (average 30 pages)
SKU: 26-014KA
The in vitro diagnostics (IVD) industry is a cornerstone of modern healthcare, empowering clinicians to detect disease, monitor health conditions, and guide treatment decisions with precision. As healthcare continues to evolve—driven by rising rates of chronic conditions such as diabetes and cardiovascular disease, along with ongoing and emerging infectious threats—the IVD market is undergoing constant change and growth.
In Vitro Diagnostics Business Outlook is a monthly intelligence publication designed to help industry professionals stay current in this fast-moving environment. Delivered in 12 issues annually, each issue focuses on a different segment of the IVD industry, providing timely insights, exclusive data, and in-depth analysis.
Featured Content
Each monthly issue provides:
-
Market Data and Forecasts
Detailed growth rates, market size, and market share to help identify emerging opportunities. -
Comprehensive Market View
Coverage of key test categories and profiles of active companies across the IVD landscape. -
M&A Activity Tracking
Updates on mergers, acquisitions, partnerships, and collaborations shaping the market. -
Industry & Region Watch
Analysis of regional and segment-specific trends to support tailored strategic planning. -
In-Depth News Analysis
Reporting on significant developments and events, including exclusive information not readily available elsewhere.
2026 Editorial Focus
Topics vary month to month, reflecting evolving industry priorities. In 2026, subscribers can expect issues dedicated to:
-
Reimbursement trends
-
Quality control reagents
-
Cardiac markers
-
STI point-of-care testing
-
Non-respiratory infectious diseases
-
An overall IVD market trend analysis
-
A forward-looking forecast of the respiratory testing market through 2027
- And more!
By delivering focused, actionable intelligence directly to subscribers’ each month, In Vitro Diagnostics Business Outlook helps decision-makers anticipate market shifts, identify growth opportunities, and navigate the complexities of the global IVD industry with confidence.
Table: Global Lab-Based Immunoassay Market, by Segment, 2026-2031 ($ million)
| Segment | 2026 | % Mkt | 2031 | % Mkt | CAGR |
| Allergy | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Anemia | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Autoimmune | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Blood Bank Screening | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Cardiac Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| COVID-19 | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Diabetes/HbA1c | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Fertility | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HAIs/Sepsis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Hepatitis | $XX Million | $XX Million | $XX Million | XX% | XX% |
| HIV | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Lyme disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Mycology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Parasitology | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Proteins | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Respiratory (excl. COVID) | $XX Million | $XX Million | $XX Million | XX% | XX% |
| STD | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Therapeutic Drugs | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Thyroid | $XX Million | $XX Million | $XX Million | XX% | XX% |
| ToRCH | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tox/Drug of Abuse | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Tumor Markers | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Vitamin D | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Other Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
| Others Non-Infectious Disease | $XX Million | $XX Million | $XX Million | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
In Vitro Diagnostics Business Outlook, Volume 5, Issue 1 – Focus on Reimbursement
Market Analysis: Reimbursement
Overview of IVD Reimbursement
Outlook: Reimbursement
- Figure: CMS Average Reimbursement Trend: 40+ High-Frequency Clinical Laboratory Test Codes
- Table: CMS Reimbursement Limit by Clinical Laboratory Test Code, 2010, 2015, 2020, and 2025
- Table: Select Companies/Products Expected 2026 Reimbursement Impact
- Table: Summary of Key Reimbursement Drivers
Executive News Briefing
Briefings
Kiffik Biomedical Closes Series A Financing
NeoGenomics Appoints Jack Kenny to Board of Directors
Cardio Diagnostics Launches Precision CHD Test in India
Cyclomics Closes €2.5 Million Investment Round
Truvian Appoints New Chief Medical and Strategy Officer
Alamar Biosciences Closes $50 Million in New Capital
Alamar Biosciences Welcomes New CSO
Hummingbird Diagnostics Appoints New CEO
Precede Biosciences Nabs $83.5 Million in Total Financing
Financial Highlights
Agilent Full Year Fiscal 2025 Sales up 7% in Business YOY
- Figure: Agilent Sales by Business, FY 2024 and 2025 ($)
- Figure: Agilent Sales by Business, FY 2025 Quarterly Performance ($)
- Table: Agilent Revenue Mix, by Type, FY 2025 (%)
- Figure: Agilent FY 2025 Regional Sales Breakdown Distribution (%)
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Mergers and Acquisitions
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Partnerships and Collaborations
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
Australia
- Figure: Australia Exports, Distribution by Industry Segment, 2023 ($ billion)
- Figure: Australia IVD Market Sales Trend, 2020-2025 ($ million)
Broad-based Company Announcements
Announcements
Mira Precision Health Launches ToxNav in U.S.
Beckton Dickinson Receives FDA Clearance and CE Marking
QuidelOrtho Captures FDA Clearance or VITROS Immunodiagnostic
FDA Proposes Reclassification of Companion Diagnostic Assays
Congress Discusses PAMA
MeMed Accelerates AI-enabled Acute-Care Diagnostics
Truvian Health Snags Clearance for Nine Additional Analytes
In Vitro Diagnostics Business Outlook, Volume 5, Issue 2 – Focus on Quality Control
Market Analysis: IVD Quality Control
Overview of IVD Quality Control
Market Outlook: IVD Quality Control
- Figure: IVD Quality Control Market, by Concentration, 2025 (%) [Immunoassay, Molecular]
- Figure: IVD Quality Control Market, 2020-2025, 2030 Est. ($ million)
Company Briefs
Bio‑Rad
Thermo Fisher
Executive News Briefing
Biomakers Closes Additional Funding
Cleveland Diagnostic Appoints New CEO
Cleveland Diagnostics Appoints New Board
Waters Announced Appointment of New Board Member
Hologic Total Revenues Remain Steady but Changes on the Horizon
- Table: Hologic Product Revenues Performance, by Product Group, FY2025 ($ million)
- Figure: Hologic Geographic Revenue Distribution, FY2025 (%)
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Mergers and Acquisitions
- Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals
Partnerships and Collaborations
Industry Watch
Industry Watch COVID-19/Flu Update
Region Watch
Saudi Arabia
- Figure: Saudi Arabia Population Pyramid, 2025 and 2050
- Figure: Saudi Arabia – Total Annual Liquid Fuels Production and Consumption, 2013-2023 (millions of barrels)
- Figure: Saudi Arabia IVD Market Share, by Broad IVD Segment, 2025 (%)
Broad-based Company Announcements
Cepheid Lands FDA Clearance for Xpert GI Panel
Truvian Health Scores Another FDA Clearance for CBC
Guardant Health Received FDA Approval for Companion Diagnostic
Diasorin Secures De Novo FDA Authorization
Quest Diagnostics Launches New Test
Biophysical Marker Test for Autism
Randox Secures FDA Clearance for New Clinical Testing Panel
Hologic Nabs FDA Approval for Aptima HPV Assay
OraSure Launches OraQuick HIV Self-Test in Canada
BillionToOne Expands Leadership in Hemolytic Disease
Athelas Receives FDA Clearance
New England Biolabs Launches New Product
LEX Diagnostics Scores FDA Clearance for VELO System
Promega Announces Approval of MSI Detection Kit in China
Related products
COVID-19 Testing Markets, 2023
May 18, 2023
As the COVID-19 pandemic evolves into an endemic phase, the landscape of COVID-19 testing is changing rapidly. Kalorama Information’s COVID-19 Testing Markets, 2023 report provides crucial insights into this shifting market, answering key questions and providing valuable market sizing and estimates.
Key Insights Provided:
- Market impacts and trends in the evolving COVID-19 testing…
Price range: $4,000.00 through $6,000.00
At-Home Diagnostic Testing Markets and Trends, 2023
June 6, 2023
Kalorama Information’s report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests), 2023, delves into the expanding world of at-home and home collection tests. The at-home in vitro diagnostic (IVD) testing market comprises tests that can be purchased over the counter or online, where patients collect specimens and receive results within…
Price range: $4,000.00 through $6,000.00
30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]
October 27, 2023
The in vitro diagnostics (IVD) market is a global multi-billion-dollar industry, with significant revenue generated outside the United States. To facilitate successful business planning, it’s crucial to assess regional and country-level IVD markets. Kalorama’s 30 Country IVD Market Atlas report offers detailed insights into international markets, aiding in forecast modeling and strategic planning.
Key…
Price range: $5,000.00 through $7,500.00
